Gene · 10019
Papers2,160
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,160
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing. | bioRxiv | 2023 | 37662410 | PubTator, text mining | PubMed |
| The perspectives of NETosis on the progression of obesity and obesity-related diseases: mechanisms and applications. | Front Cell Dev Biol | 2023 | 37649550 | PubTator, text mining | PubMed |
| A novel germline hyperactivating JAK2 mutation L604F. | Ann Hematol | 2023 | 37639050 | PubTator, text mining | PubMed |
| Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1-Negative Myeloproliferative Neoplasms. | Int J Mol Sci | 2023 | 37629188 | PubTator, text mining | PubMed |
| Molecular Studies for the Early Detection of Philadelphia-Negative Myeloproliferative Neoplasms. | Int J Mol Sci | 2023 | 37628880 | PubTator, text mining | PubMed |
| Individual with concurrent chest wall tuberculosis and triple-negative essential thrombocythemia: A case report. | World J Clin Cases | 2023 | 37621591 | PubTator, text mining | PubMed |
| Convergent somatic evolution commences in utero in a germline ribosomopathy. | Nat Commun | 2023 | 37608017 | PubTator, text mining | PubMed |
| Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy. | Cell Genom | 2023 | 37601967 | PubTator, text mining | PubMed |
| Mechanism and clinical evidence of immunotherapy in allergic rhinitis. | Front Allergy | 2023 | 37601646 | PubTator, text mining | PubMed |
| RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition. | J Clin Invest | 2023 | 37581927 | PubTator, text mining | PubMed |
| Natriuretic Peptide Signaling in Uterine Biology and Preeclampsia. | Int J Mol Sci | 2023 | 37569683 | PubTator, text mining | PubMed |
| Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy. | Int J Mol Sci | 2023 | 37569625 | PubTator, text mining | PubMed |
| JAK3 Y841 Autophosphorylation Is Critical for STAT5B Activation, Kinase Domain Stability and Dimer Formation. | Int J Mol Sci | 2023 | 37569303 | PubTator, text mining | PubMed |
| Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing. | Cancers (Basel) | 2023 | 37568719 | PubTator, text mining | PubMed |
| Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. | Nat Immunol | 2023 | 37563310 | PubTator, text mining | PubMed |
| Transcriptome analysis identification of A-to-I RNA editing in granulosa cells associated with PCOS. | Front Endocrinol (Lausanne) | 2023 | 37547318 | PubTator, text mining | PubMed |
| Neoantigen Targetability in Progressive Advanced Melanoma. | Clin Cancer Res | 2023 | 37540567 | PubTator, text mining | PubMed |
| Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease. | J Transl Int Med | 2023 | 37533842 | PubTator, text mining | PubMed |
| The Emerging Role of Innate Lymphoid Cells (ILCs) and Alarmins in Celiac Disease: An Update on Pathophysiological Insights, Potential Use as Disease Biomarkers, and Therapeutic Implications. | Cells | 2023 | 37508573 | PubTator, text mining | PubMed |
| The role of IFN-γ-signalling in response to immune checkpoint blockade therapy. | Essays Biochem | 2023 | 37503572 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10019/papers?page=10